Targeted doxorubicin-liposomes as a tool to circumvent P-gp-mediated resistance in ovarian carcinoma cells

International Journal of Clinical Pharmacology and Therapeutics

Volumn 48, Issue 7, 2010, Pages 442-444

  Krieger, M L ^a   Konold, A ^a   Wiese, M ^a   Jaehde, U ^a   Bendas, G ^a  

^a UNIVERSITY OF BONN   (Germany)

Author keywords

Doxorubicin; Liposomal targeting; Multidrug resistance (MDR); Tumor cells

Indexed keywords

DOXORUBICIN; GLYCOPROTEIN P; GLYCOPROTEIN P INHIBITOR; LIPOSOME; MACROGOL;

CANCER CELL CULTURE; CENTRIFUGATION; CONCENTRATION (PARAMETERS); CONFERENCE PAPER; CONTROLLED STUDY; CULTURE MEDIUM; CYTOTOXICITY; DRUG ACCUMULATION; DRUG TARGETING; ENDOCYTOSIS; FEMALE; HUMAN; HUMAN CELL; OVARY CARCINOMA; PROTEIN TRANSPORT; SUPERNATANT;

EID: 77954938142     PISSN: 09461965     EISSN: None     Source Type: Journal    
DOI: 10.5414/CPP48442     Document Type: Conference Paper

References (7)

1. Bendas G, Krause A, Bakowsky U, Vogel J, Rothe U. Targetability of novel immunoliposomes prepared by a new antibody conjugation technique. Int J Pharm. 1999; 181: 79-93. (Pubitemid 29199890)
2. Goren D, Horowitz T, Tzemach D, Tarshish M, Zalipsky S, Gabizon A. Nuclear delivery of doxorubicin via folate-targeted liposomes with bypass of multidrug-resistance efflux pump. Clin Cancer Res. 2000; 6: 1949-1957. (Pubitemid 30305094)
3. Gottesman MM, Pastan I, Ambudkar SV. P-glycoprotein and multidrug resistance. Curr Opin Gen Dev. 1996; 6: 610-617.
4. Hamelers IHL, Staffhorst RWHM,Voortmann J, de Kruijff B, Reedjik J, van Bergen en Henegrouwen PMP, de Kroon AIPM. High cytotoxicity of cisplatin nanocapsules in ovarian carcinoma cells depends on the uptake by caveolae-mediated endocytosis. Clin Cancer Res. 2009; 15: 1259-1268.
5. Moreira JN, Ishida T, Gaspar R, Allen TM. Use of the post-insertion technique to insert peptide ligands into pre-formed Stealth liposomes with retention of binding activity and cytotoxicity. Pharm Res. 2002; 19: 265-269. (Pubitemid 34211842)
6. Roe M, Folkes A, Ashworth P, Brumwell J, Chima L, Hunjan S. Reversal of P-glycoprotein mediated multidrug resistance by novel anthranilamide derivatives. Bioorg Chem Med Lett. 1999; 9: 595-600. (Pubitemid 29090660)
7. XueMing L, LiYan D, Yuanlong X, Yonglu W, QiNeng P. Targeted delivery of doxorubicin using stealth liposomes modified with transferrin. Int J Pharm. 2009; 373: 116-123.